Unitedhealth Group INC Form 4 insider transactions

Stephen J. Hemsley, a director at UnitedHealth Group, reported changes in his beneficial ownership of company stock due to gift conveyances and annuity payments.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reported the sale of 2,851 shares of common stock at a weighted average price of $569.8822 and a gift of 439 shares.

Erin McSweeney, EVP & Chief People Officer of UnitedHealth Group, reported selling 1,500 shares of common stock at an average price of $579.0253 on July 18, 2024.

Paul R. Garcia, a director at UnitedHealth Group, reported a transaction involving the distribution of 30 UNH shares from a trust to its beneficiary on July 18, 2024.

Director Valerie Montgomery Rice acquired 190 shares of UnitedHealth Group common stock as part of her quarterly compensation for serving on the board.

Director Paul R. Garcia reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Director Kristen Gil reports acquisition of UnitedHealth Group common stock and deferred stock units as part of regular quarterly compensation.

Director Timothy Flynn reports acquiring 190 shares of UnitedHealth Group common stock as part of deferred stock units granted for board service.

John H. Noseworthy, a director at UnitedHealth Group, acquired 190 shares of common stock on July 1, 2024, as part of his director compensation.

Director Charles D. Baker reports acquisition of 177 deferred stock units of UnitedHealth Group as part of quarterly compensation.

Director Stephen J. Hemsley reports acquisition of deferred stock units and adjustments to beneficial ownership of UnitedHealth Group stock.

Director Frederick William McNabb III acquired 194 deferred stock units of UnitedHealth Group on July 1, 2024, as part of his quarterly compensation for board service.

Director Michele J. Hooper reports acquiring 114 deferred stock units of UnitedHealth Group as part of regular quarterly compensation.

Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Brian R. Thompson, CEO of UnitedHealthcare, reported changes in beneficial ownership of UnitedHealth Group stock, including the acquisition of dividend equivalents and disposal of common stock.

Frederick William McNabb III, a director at UnitedHealth Group, acquired 28 shares of common stock through dividend equivalents on vested deferred stock units.

Director Stephen J. Hemsley reports acquiring 28 shares of UnitedHealth Group common stock through dividend equivalents, according to a Form 4 filing.

EVP & Chief People Officer of UnitedHealth Group, Erin McSweeney, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.

John H. Noseworthy, a director at UnitedHealth Group, acquired 22 shares of common stock through dividend equivalents on June 25, 2024.

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents related to restricted stock units.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.

Director Valerie Montgomery Rice acquired 22 shares of UnitedHealth Group common stock through dividend equivalents on vested deferred stock units.

Director Kristen Gil reports acquisition of common stock and dividend equivalents, and disposal of common stock.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.

Director Timothy Flynn reported acquiring 36 shares of UnitedHealth Group common stock as dividend equivalents and disposing of 2,000 shares held indirectly through a trust.

Director Michele J. Hooper acquired 155 shares of UnitedHealth Group common stock through dividend equivalents, increasing her direct holdings to 39,168 shares.

Director Paul R. Garcia reports a transaction involving UnitedHealth Group common stock, including the acquisition of dividend equivalents.

Heather Cianfrocco, Chief Executive Officer of Optum, reports acquisition and disposal of UnitedHealth Group common stock due to dividend equivalents.

Andrew Witty, CEO of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents and disposal of common stock.

Stephen J. Hemsley, a director at UnitedHealth Group, executed multiple transactions involving the exercise of non-qualified stock options and the subsequent disposition of shares to cover tax obligations on June 14, 2024.